GeneProt, based in Evanston, Ill., has made three appointments to its senior management team.
Bertrand Damour, most recently senior vice president and co-head of the investment banking risk management group at JP Morgan in London, joined the company as CFO; Stephen Macevicz, formerly vice president of legal affairs at Lynx Therapeutics, was hired as vice president of intellectual property; and Diana Wetmore, most recently senior director of R&D project management at Anadys Pharmaceuticals, will serve as CTO for GeneProts Geneva branch.
Pittsburgh-based bioinformatics incubator LaunchCyte has appointed seven new science and business executives to its advisory board: Ben Bowen, vice president of application development for Lynx Therapeutics; S. Thomas Emerson, director of the Donald H. Jones Center for Entrepreneurship at Carnegie Mellon University; George Fechter, associate vice chancellor for external relations of the health sciences at the University of Pittsburgh; Jack Kincaid, CEO of IT accelerator Business Strategies Group; Henri Lipmanowicz, former chief of international operations for Merck; Alan Russell, executive director of the Pittsburgh Tissue Engineering Initiative; Robert Shapiro, former CEO of Monsanto and recently retired chairman of Pharmacia Corp.; and Mohamed Virji, director for the division of clinical chemistry in the department of pathology at the University of Pittsburgh School of Medicine and the Medical Center.
Paul Jackson and Thomas Terwilliger of the Bioscience Division of Los Alamos National Laboratory were among six new Laboratory Fellows recently selected by lab director John Browne. The distinction is the labs highest scientific honor.
Jackson was recognized for his research in molecular and cellular biology, while Terwilliger was recognized for his role in the development of the computer program Solve, which creates automated solutions of protein crystal structures from X-ray diffraction data sets.